Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Goldman Sachs Ups Bausch & Lomb to InLine


From Standard & Poor's Equity Research

Goldman Sachs upgraded Bausch & Lomb (BOL) to inline from underperform, noting that share prices already reflect collateral damage to the company's U.S. ReNu franchise.

Analyst Lawrence Keusch says a recent Goldman survey of 174 soft contact lens wearers to assess contact lens solutions buying patterns found: awareness of Fusarium keratitis was highest in U.S., Asia ex-Japan; questions in the survey assessing willingness to purchase ReNu products suggest market share erosion in ReNu franchise is largely contained to the U.S.; collateral damage to the U.S. ReNu franchise seems largely reflected in shares. While he sees a lack of catalysts over the next several quarters, he thinks the risk/reward is more balanced given that market share declines seem reflected in the stock.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus